Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
c.IVS38-1G>A (c.4817-1G>A) | Heterozygous | Mutation |
wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
GAT | Asp | spl-1 | Spl. | G->A | Ts |
Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
cb EGF-like #23 | Ca2+ binding |
At the mRNA level | On restriction map |
Not tested on cDNA | New restriction site(s): none Lost restriction site(s): none |
Impact on splicing | ||||||||||
Splice site type | Wild type sequence | CV | Mutant type sequence | CV | Variation (%) | |||||
tgattttgatagAT |
| tgattttgataaAT |
| -37.9 % |
Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
GER03HAN F0022 I01 | Proband | Female | familial | 7 years old | GERMANY |
Phenotypic group | Disease |
NA | Classical MFS |
Symptom |
C-Mitral valve prolapse |
no clinical data |
O-Ectopia lentis |
S-Arachnodactyly (M) |
S-Dolichostenomelia |
S-Increased body length |
S-Joint hypermobility (m) |
S-Scoliosis > 20° (M)(1) |
Reference ID | PubMed ID | Reference |
107 | 12402346 | Rommel K, Karck M, Haverich A, Schmidtke J, Arslan-Kirchner M. "Mutation screening of the fibrillin-1 (FBN1) gene in 76 unrelated patients with Marfan syndrome or Marfanoid features leads to the identification of 11 novel and three previously reported mutations". Hum Mutat. 2002 Nov;20(5):406-7. |